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pandemic, healthcare organizations began concentrating on the prepa-
ration for andmanagement of the surge of COVID-19 cases while trying
to protect the healthcare workers and other patients from getting
COVID-19 (Rosenbaum, 2020; Al-Tawfiq et al., 2020a). This latter task
is critically important as patients are the most vulnerable victims of
COVID-19 because they are usually older adults, with chronic medical
conditions, frequently multiple, or immunocompromised. The rapid
adoption of alternative ways to deal with those patients was unprece-
dented across the globe. The actions implemented by the different
healthcare organizations fell into one or another of the categories of
controls illustrated in the hierarchy of controls, popularized by the
United States Centers for Disease Control and Prevention (CDC) (CDC,
n.d.). The most immediate intervention was the mandatory use of per-
sonal protective equipment (PPE) of different nature when dealing
with confirmed or suspected cases of COVID-19.
The risk of aerosolization and thus the risk of dissemination of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seemhigher in
certain surgical and aerosol-generating procedures (Vukkadala et al.,
2020; Workman et al., 2020). For those procedures, appropriate PPE in-
cluding N-95 or PAPR use is needed during these procedures, aerosol-.
In addition to these measures, alternative nonsurgical management
strategies, should be sought (Fastenberg et al., 2020).
Changing the way people work requires innovative approaches and
questioning some long-held medical practices. Medical therapy such asin the case of acute coronary syndrome catheterization is presently un-
dergoing re-evaluation, where nonsurgical interventions such as the
use of thrombolysis therapies are being considered in place of catheter-
ization (Welt et al., 2020). In one study of urologic services, 19 of 53
(35.8%) consultations were performed via telemedicine (Borchert
et al., 2020). Adopting virtual visits through telephone calls and video
calls is another avenue of great potential. This is particularly helpful
for patients who do not require invasive procedure and do not require
in-hospital care. These visits will allow the healthcare worker to assess
the patient’s progress and response to therapy, and to adjust or refill
medications. Clearly, each country’s laws and regulation need to be
supporting the legality of virtual visits. In combination with virtual
visits, home delivery or delivery at satellite pharmacy locations is be-
coming more popular. Our own organization has implemented in se-
lected cases both virtual visits and home delivery of medications.
The next category of intervention consists of isolating people from the
hazard. Many healthcare organizations, including ours, decided to defer
certain procedures and elective cases in order to lower the risk of trans-
mission (Welt et al., 2020). Various factors are used for classifications to
prioritize non–COVID-19 patients depending on the acuity of the disease,
risk of intensifying chronic disease symptoms without intervention, risk
of exposure to COVID-19 in relation to geography, and availability of tech-
nology with video capabilities. One such classification of patients was
based on the urgency of the condition, creating the following 4 categories:
care needed in 0–6 h, 6–48 h, 48 h to 14 days, and >14 days (Fastenberg
et al., 2020). That organization functioned on the presumption that all pa-
tients and staff could be positive asymptomatic cases requiring social dis-









Fig. 1. Venn diagram showing a complex interaction of multiple factors contributing to
effect of COVID-19 on non–COVID-19 cases.
Table 1
Appropriate precautions to reduce the chances of SARS-CoV-2 transmission in the
clinic.
Call the clinic ahead of time
• Practice hand hygiene
• Follow social distancing guidelines
• Minimize physical contact
• Clean and disinfect surfaces and frequently touched items
• Respiratory triage to elucidate symptoms, exposure to COVID-19, and travel
questions on arrival to the clinic
• Wear PPE
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2020; Tirupathi et al., 2020).
The concern about possible transmission of COVID-19 in the hospital
setting has also moved the practice frommore invasive tomore conser-
vative procedures. Evidence-based medicine articles looked at various
medications, such as aspirin, B-blocks, angiotensin-converting enzyme
inhibitors, and statin therapy that could reduce non–COVID-19 hospital
admission (Bobrovitz et al., 2020). Hospitals developed internal policies
limiting sitters and companion in the units and ensuring compliance
with universal masking for both healthcare worker as well as the pa-
tients, social distancing, hand hygiene, and cough etiquette.
Hospitals began screening each visitor (patients and staff) for history
of COVID-19 symptoms, and checking the temperature was adopted,
directing those identified as possible COVID-19 patients to the appropri-
ate testing facilities and disposition (Johns Hopkins Aramco Healthcare,
n.d.). Furthermore, in order to properly care for non–COVID-19patients,
it had been suggested that there should be separate hospitals for those
with COVID-19 and those without COVID-19 (Welt et al., 2020), intro-
ducing the concept of segregation at the level of the hospital rather
than the level of a unit or ward in a specific hospital.
To be prepared for a potential surge in the need for intensive care
beds for COVID-19 patients, major logistical efforts become necessary.
Logistics and preparedness of healthcare organization to accommo-
date non–COVID-19 patients such as the availability of ICU beds for
both non-COVID and COVID-19 patients rely on other community ac-
tivities for the control of COVID-19, such as self-isolation, quarantine
facilities, and curfew. In one study, the need for ICU beds was esti-
mated to be 569 ICU bed days per 10,000 population in case of no
self-isolation of infected patients (Moghadas et al., 2020). This number
is reduced by 23.5% and 53.6% assuming that 20% and 40% of cases
practiced self-isolation, respectively (Moghadas et al., 2020). The
true need of hospital, and in particular ICU, beds actually seems depen-
dent on several factors. A very important (and controllable) factor is
the policy regardingmanagement of confirmed positive asymptomatic
cases. The option, sanctioned by the local government, to (success-
fully) quarantine such patients at home or in designated quarantine fa-
cilities would dramatically “decompress” healthcare organizations
that would then focus on symptomatic patients only. Another impor-
tant (but noncontrollable) factor determining the need of hospital
beds is the average age of the population. As it became apparent in
Europe, nations with a high percentage of elderly individuals cared
for in nursing and retirement homes have experienced an overwhelm-
ing surge of severely symptomatic elderly individuals with an associ-
ated mortality 1 order of magnitude higher than nations with a
lower average age (Al-Tawfiq et al., 2020b). The US CDC had proposed
for nursing home residents who are asymptomatic to have increasing
monitoring from daily to every shift to more rapidly detect any resi-
dent with new symptoms (CDC, 2020). However, how those asymp-
tomatic COVID-19–positive patients in nursing homes or other long-
term care facilities should be managed is not clear.
However, it is not clear how to protect patients and healthcare
workers from those so-called “non–COVID-19” who might be
asymptomatically infected with SARS-CoV-2. Would routine naso-
pharyngeal swabs and polymerase chain reaction testing be screen-
ing of high enough sensitivity that a negative test would indicate
that those patients are not infected? What about those who might
be incubating or are in the presymptomatic stage? Data suggest
that the nasopharyngeal swab had about 75% positivity from a
single swab and that 3 swabs are needed to reach more than 95%
(Al-Tawfiq and Memish, 2020a). The utility of antibody use in the
diagnosis of COVID-19 had not been recommended at this time.
Currently, the evidence for the use of serologic testing of SARS-
CoV-2 is not optimal. Serologic tests have variable sensitivity and
specificity, with different timing of the appearance of these anti-
bodies, and it is not clear if these antibodies confirm protection
(Al-Tawfiq and Memish, 2020b).All the measures mentioned above had dramatic effects on the utili-
zation of healthcare resources. One study reported a decrease by up to
75% of referrals for suspected cancer (Fastenberg et al., 2020). Another
study showed a reduction in trauma-related cases in emergency depart-
ment and hospital admissions (Christey et al., 2020). In an additional
study, the emergency room visits of non–COVID-19 patients had signif-
icantly decreased over time in Italy due to the COVID-19 pandemic
(Hartnett et al., 2020). In a study of 2537 dental visits, dental urgent
visits decreased by 38% and nonurgent case visits decreased by 45%
(Guo et al., 2020). A recent report pointed out a decreased number of
admissions for emergencies such as coronary artery disease and cere-
brovascular accidents (Garcia et al., 2020). Similarly, there was a reduc-
tion of 39.4% of patients admitted with acute coronary syndrome
(Metzler et al., 2020).
There are multiple factors contributing to the apparent reduced uti-
lization of healthcare services by non–COVID-19 patients. Firstly, there
is a fear to visit clinics as they might be a place carrying a higher risk
of getting infected with SARS-CoV-2 (Rosenbaum, 2020). There are
other factors contributing to low patient volume of non–COVID-19 in
the healthcare system (Fig. 1) besides the fear of patient of becoming in-
fected, as mentioned previously. The greatly curtailed ability tomove at
times of curfew or lockdown is creating a new challenge. Additional fac-
tors include the reduced offering of nonurgent and routine clinic visits
or their outright cancellation. The underlying causes for such adminis-
trative decisions include the desire to decrease the crowding and its as-
sociated increased risk of spread and decreased availability of
healthcare workers, often reassigned to meet the increasing demand
to care for COVID.
It is becoming evident, however, that we need to develop new solu-
tions on how healthcare organizations should provide care of non–
COVID-19 patients, especially those with chronic diseases. While
insisting on keeping patients outside the hospital as much as possible
to enhance physical distancing, it is important to bolster social support,
3J.A. Al-Tawfiq et al. / Diagnostic Microbiology and Infectious Disease 98 (2020) 115147as patients might need to come to clinic and not be able to visit the
clinics independently. Healthcare workers must take the appropriate
precautions to reduce the transmissions of SARS-CoV-2 in the
healthcare settings (See Table 1.). It is the duty of healthcare profes-
sionals to reach out to those patients as they feel they are invisible
(Welt et al., 2020).
In conclusion, the current COVID-19 pandemic has affected howwe
treat non–COVID-19 patients and challenged long-held assumptions on
how to deliver proper medical care. It behooves healthcare organiza-
tions to rethink the way care is provided to COVID-19 and non–
COVID-19 patients. Things such virtual visits are an excellent comple-
ment to the existing care delivery paradigms and are likely to continue
after the pandemic. It is, however, equally clear that even if this pan-
demic is eventually over and a vaccine can remove the risk of infection
and spread of COVID-19, the current world crisis is highlighting the
need of re-engineering the way we deliver inpatient and outpatient
health-care, including bolstering social support, in order to be prepared
when the next calamity will present itself..
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